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relationshipAbstract Fatty acids themselves have a number of biological properties and its easy intake by the
human body will focus to the synthesis of many heterocyclic moiety substituted with fatty acid
residue, to make more gradual intake of heterocycles in the human body. 2,5-Dimethyl pyrrole
2(a–e) and 1,3-benzoxazin-4-one 4(b–e) derivatives were synthesized, from cyclization of fatty acid
hydrazide 1(a–e) with acetonyl acetone and from the reaction of fatty esters 3(b–e) with anthranilic
acid in the presence of POCl3, respectively. All these compounds were characterized with the help of
IR, 1H NMR, 13C NMR and mass spectra. The synthesized compounds were screened for
antimicrobial evaluation against gram-positive (Staphylococcus aureus SA 22, Bacillus subtilis
MTCC 121), gram-negative (Escherichia coli K12, Klebsiella pneumoniae) and fungal strains
(Candida albicans IOA-109) and were found to be good antimicrobial agents.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The pyrrole ring is a part of many biological compounds such
as the enzyme catalase, the bile pigment bilirubin and the
mould pigment prodigiosin; it is also a signiﬁcant part of
macrocyclic porphyrin ring system of chlorophyll and hemin[1,2]. Apart from these properties pyrrole and its derivative
possess a number of biological activities such as antiallergic,
antitumor [3], antibacterial, antifungal [4], antiinﬂammatory,
analgesic [5], anticonvulsant [6], antimycobacterial [7] antitu-
bercular, anticancer [8] and anti HIV [9]. Substituted dimethyl
pyrroles can be synthesized from the widely used Knorr
pyrrole synthesis [10]. Other methods are also known for the
synthesis of 2,5-dimethyl pyrrole derivatives [11,12]. Some-
times for the synthesis of substituted pyrroles, photochemical
reactions are also used, which involves the use of other pyrrole
precursor including the migration of group from one nitrogen
atom to the ring carbon atom [13]. Despite the biological use
of substituted dimethyl pyrroles they have been synthetically
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Scheme 1 Synthetic pathway for the synthesis of a series of N-fatty acid derivative substituted 2,5-dimethyl pyrrole and 2-alkenyl/
hydroxyalkenyl chain substituted-benz-1,3-oxazin-4-one.
Synthesis of 2,5-dimethyl pyrrole and 1,3-benzoxazin-4-one derivatives S395very useful compounds. In the solid phase synthesis 2,5-
dimethyl pyrroles can be used as a good protecting group for
protecting the terminal amines. Solid supported 2,5-dimethyl
pyrrole was obtained in pure form and quantitative yield by
microwave irradiation using dimethyl pyridine (DMP) as sol-
vent. The microwave irradiation speeds up the reaction rate
and solid supported pyrrole derivative was obtained only in
ﬁve minutes [14]. These 2,5-dimethyl pyrroles, undergo reduc-
tive condensation (did not undergo self condensation) with
acetonyl acetone to form 1,3-diphenyl-4,7-dimethyl isoindoline
[1,2]. Various methods are known for the synthesis of dimethyl
pyrrole derivatives using different reagents and substrates,
these derivatives were found very useful in the ﬁeld of
chemistry as well as in biology [15–20]. Preliminary data on
the synthesis of substituted pyrrole derivative of saturated
fatty acid (stearic acid) have been already reported [21], but
the unsaturated fatty acid amide substitution on 2,5-disubsti-
tuted pyrrole has not been reported yet.
On the other hand, 1,3-benzoxazin-4-one derivatives are
biologically very useful compounds [22]. These are used eitherdirectly or indirectly in many ﬁelds such as industries [23],
research ﬁeld and in clinical work [24]. Clinically used 4-qui-
nazolone derivatives were synthesized from benzoxazinone
starting material [25]. Vinyl and phosphate group substituted
benzoxazinone derivatives were used as hypnotic drug [26],
antiphlogistic drug [27] and possessed antimuscular contrac-
tion properties [28]. These derivatives are very useful in natural
product chemistry, because they were found in the form of ace-
tal glycosides in plant of different taxonomic positions [29].
Nitrogen atom of these derivatives is a part of the aglyconic
cyclo hemiacetal unit, therefore it can act as a plant’s own
resistance factor towards pests, insects, fungi and other micro-
bial diseases. A conjugate base benzoxazine kanamycin can be
used as a suitable ﬂuorescent nucleus (probe) for detecting the
mycoplasmas in cell culture [30]. These derivatives also proved
to be neuropeptide Y Y5 receptor antagonists through quanti-
tative structure activity relationship (QSAR) studies [31] and
also as factor Xa (FXa) inhibitor (it is a trypsin like protease,
helps in blood coagulation) [32]. The 1,3-benzoxazin-4-one
undergoes nucleophilic ring opening reaction with Ruppert’s
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fig 1:Antibacterial activity against C. albicans 
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fig 2:Antibacterial activity against B. subtilis
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fig 3:Antibacterial activity against S. aureus
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fig 4:Antibacterial activity against E.coli 
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fig 5:Antibacterial activity against K. pneumoniae 
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Figure 1 Showing the antimicrobial activity against various
microbes. Fig. (1) shows the antifungal activity against Candida
albicans, standard used was Nystatin. Figs. (2–5) show the
antibacterial activity against Bacillus subtilis, Staphylococcus
aureus, Escherichia coli, Klebsiella pneumoniae, respectively, stan-
dard used was Ciproﬂoxacin.
S396 H. Varshney et al.reagent (TMS-CF3) to form triﬂuoro methylated compound
(o-amino-2,2,2-triﬂuoroacetophenones) that is a useful
compound in modern drug discovery and material sciences
[33]. Benzoxazinones were synthesized from the different meth-
ods which include condensation reaction of anthranilic acid
amide with cyanuric chloride, elimination of hydrochloride
(HCl) and benzoxazinone [25]. Another method of synthesis
of benzoxazinone derivatives was reﬂuxing of mixture of ben-
zoic acid derivatives with acetic anhydride [34]. Besides this,
the drugs containing fatty acid chain residues played a vital
role in modern drug discovery. Some of the newly synthesized
bacterial fatty acids were purchased by the number of research
groups to develop or produce new antibacterial agents (anti
staphylococcal agents) [35]. But we have synthesized these
derivatives through the reaction of fatty acid methyl esters
and anthranilic acid in dry benzene solvent with catalytic
amount of POCl3 and pyridine. Anthranilic acid is used here,
because of its amino acidic nature and may be used as a useful
precursor for pharmaceutics [36]. Therefore, in view of the
above mentioned ﬁndings and properties, the aim of the pres-
ent work was to design, synthesize, analyse and evaluate anti-
microbial activity of some novel long chain hydroxy and non
hydroxy fatty acid derivatives of 2,5-dimethyl pyrroles and
1,3-benzoxazin-4-ones.
2. Results and discussion
2.1. Chemistry
Long chain alkenyl/hydroxy alkenyl acids (fatty acids) were
used as a starting material for the synthesis of fatty acid hydra-
zides 1(a–e) and fatty acid methyl esters 3(b–e), depicted in
Scheme 1. Long chain saturated and unsaturated fatty acid
hydrazides 1(a–e) reacted with the 2,5-hexadione to form the
corresponding compounds 2(a–e) in ethanol presented in
Scheme 1. These newly synthesized fatty acid substituted
dimethyl pyrrole derivatives 2(a–e) were found to be good
antimicrobial agents because it has been suggested that the
fatty acid may increase antibacterial and antifungal activity
of number of organic heterocyclic moieties [37–40], graphically
depicted in Fig. 1, and the antimicrobial screening data were
given in Table 2. Compounds 2b, 2d, 2e were found to be good
antibacterial as well as good antifungal agent. Apart from this,
the other novel series of heterocyclic derivatives (benzoxazi-
none derivatives) of fatty acids 4(b–e) were synthesized from
reﬂuxing the mixture of fatty acid methyl esters 3(b–e) and
anthranilic acid in dry benzene solvent, in the presence of
catalytic amount of pyridine and POCl3, presented in
Scheme 1. The physico-chemical properties of all newly synthe-
sized compounds are given in Table 1. These compounds were
also screened for the antimicrobial activity and showed moder-
ate to good results. Compound 4b and 4c were found to be
potent antibacterial agents against gram-negative bacterial
species as compared to the gram-positive bacteria. All the
synthesized compounds were characterized with the help of
IR, 1H NMR, 13C NMR and mass spectra. Detailed spectral
description of the compound 2b is given below.
This compound showed characteristic peaks in the IR
spectrum for the functional groups. The peaks obtained at
3259 cm1 for NH stretching, at 1672 and 1082 cm1 for
C‚O and C–N stretching, respectively. 1H NMR spectra werevery useful in assigning the structure of the synthesized com-
pound. This newly synthesized compound showed a diagnostic
Table 1 Physico-chemical properties of newly synthesized compounds 2(a–e) and 4(b–e).
Comp. code Compound Mole. weight Colour and Physical State M.P. (C) % Yield
2(a)
NH
O
12 N
H3C
H3C
348.49 White powder 120–122 82
2(b)
4
HZ
HE
NHN
H3C
H3C
O 276.36 White powder 96–98 71
2(c)
N
H3C
H3C
5 5 NH
O 374.52 Pale yellow powder 116–118 76
2(d)
N
H3C
H3C
OH
3 6 NH
O
390.52 Yellow powder 111–113 73
2(e)
N
H3C
H3C
OH
2 6 NH
O 390.52 Dark yellow powder 116–117 69
4(b)
4
HZ
HE
N
C
O
C
O
285.34 Pale yellow Oily Liquid - 69
4(c) N
C
O
C
O
5 4
383.50 Light yellow Oily liquid - 74
4(d)
N
C
O
C
O
OH
3 4
399.50 Yellow liquid - 73
4(e) N
C
O
C
O
OH
2 5
399.50 Yellow Liquid - 68
Synthesis of 2,5-dimethyl pyrrole and 1,3-benzoxazin-4-one derivatives S397singlet at d 7.98 for NH proton, a doublet at d 5.72 for ring
protons. In case of unsubstituted pyrrole, ring protons showed
the chemical shift value at or above the 6.1 ppm but in case of
dimethyl substituted pyrrole derivatives the position of pro-
tons attached to the C3 and C4 carbons of the pyrrole ring,
shifted to lower (d 5.70–5.85) delta value (upﬁeld side) this is
because of the shielding effect of the electron releasing methylgroups (attached at 2 and 5 position of the pyrrole ring) on the
neighbouring protons (C3 and C4 ring protons). The methine
proton of C10 showed triplet of doublet of doublet (tdd) at d
5.76. The C11 methylene protons HZ and HE showed two dis-
tinct doublets of doublet (dd) at d 4.91 and at d 4.85, respec-
tively. A singlet was observed at d 2.00 for six methyl
protons. 13C NMR spectrum also showed the peaks of ring
Table 2 In vitro antibacterial and antifungal activity data (resulting zones of inhibition were measured in millimetres) against various
microbes at 2 different concentrations of compounds 2(a–e) and 4(b–e).
Compound Concentration (lg/ml) Bacillus subtilis Staphylococcus aureus Escherichia coli Klebsiella pneumoniae Candida albicans
2a 400 – – – – –
800 13 11 14 12 15
2b 400 15 – 16 14 17
800 18 16 17 16 18
2c 400 – – 12 12 –
800 14 14 16 13 15
2d 400 16 – 16 19 –
800 19 18 21 20 18
2e 400 – 15 15 18 –
800 18 20 22 21 17
4b 400 16 12 – – –
800 18 18 15 17 19
4c 400 – 12 – 14 –
800 15 15 17 18 16
4d 400 – 11 17 18 16
800 19 19 22 21 20
4e 400 14 16 17 18 15
800 19 20 23 22 19
Ciproﬂoxacin 30 (lg/disc) 18 20 21 23 –
Nystatin 30 (lg/disc) – – – – 19
S398 H. Varshney et al.carbon atoms at d 126.7, 125.3, 104.2 and 103.1 as well as for
the chain carbon atoms. Mass spectra of the synthesized com-
pound satisﬁed the assigned molecular formula.
Spectral description of the compound 4b is discussed
here. IR spectra of the compound showed the peaks at
3075 cm1 for the aromatic CH stretching, at 1659 cm1
for C‚O stretching, at 1523 cm1 for C‚N stretching
and at 1090 cm1 for C–N stretching. 1H NMR spectra of
the compound showed the following peaks. Two multiplets
were observed at d 8.35, 7.33 for four aromatic protons.
The C9 methine proton of the fatty ester substitution
showed the tdd at d 5.80 and two methylene protons HZ
and HE of C10 showed two distinct dd at d 4.99 and 4.92
respectively. 13C NMR spectra of the compound showed
the diagnostic peaks at d 174.4 (C‚O carbon), 171.2
(C‚N carbon), 142.2, 134.3, 131.6, 130.8, 129.9, 128.2,
124.5 and 122.6 for benzene ring and unsaturated carbons,
respectively. The molecular ion peak was also consistent
with the calculated molecular weight of the synthesized
compound.
2.2. Biology
All the synthesized compounds were tested for in vitro antimi-
crobial activity against gram- positive, gram-negative bacteria
and fungi. Antibacterial activity was tested against two gram-
positive species Staphylococcus aureus SA 22, Bacillus subtilis
MTCC 121 and two gram- negative species Escherichia coli
K12, Klebsiella pneumoniae. In vitro antifungal activity was
tested against the species Candida albicans IOA-109. These
newly synthesized compounds were tested at 400 and 800 lg/
ml diameter of the zone of inhibition in mm. The minimum
inhibitory concentration (MIC) of the synthesized compounds
was 400 and 800 lg/ml respectively at two different diameters
of zone of inhibition. The standard used for antibacterial activ-
ity, was ciproﬂoxacin (30 lg/disc) and for antifungal activity,
was nystatin (30 lg/disc).2.3. Structure activity relationship
Biological activity of any organic compound is directly related
to its structure. The activity of the compound is greatly
affected by the presence and absence of different functional
groups and substituents. All the synthesized compounds 2(a–
e) and 4(b–e) were tested against the various bacterial
(gram-negative species viz E. coli K12, K. pneumoniae and
gram-positive species S. aureus SA 22, B. subtilis MTCC
121) and fungal strains (C. albicans IOA-109). All the com-
pounds showed the distinct effect of biological activity against
these microbes depending upon their structures. Among the
two series of compounds, substituted 2,5-dimethyl pyrrole
derivatives 2(a–e) and substituted 1,3-benzoxazine-4-one deriv-
atives 4(b–e), compounds 4(b–e) were found to be more active
than the compounds 2(a–e), mainly because of more number
of hetero atoms in their structures. Among all the synthesized
compounds, compound 2d, 2e, 4d and 4e were found to be
good antimicrobial agents. The enhancement of the activity
of these compounds is due to the presence of the hydroxyl
group in their structures. The hydroxyl group increases the
reactivity of the compounds against the various biological
reactions. Compounds 2b and 4b, showed the good antimicro-
bial results than the compounds 2c and 4c. The presence of ter-
minal double bond in compounds 2b and 4b, increases their
reactivity than the compounds 2c and 4c, that contain internal
double bond. Compound 2a, showed least antimicrobial activ-
ity which may be attributed to the presence of long saturated
carbon chain (C17) substituent. The compounds 2d, 2e, 4d
and 4e, were found to be the most active against E. coli and
K. pneumoniae species. Maximum inhibition values were
observed for 1,3-benzoxazin-4-one derivatives with hydroxy
substituents that is 4d and 4e, against E. coli with zone diam-
eter of 17, 17 mm (at 400 lg/ml concentration) and 22, 23 mm
(at 800 lg/ml concentration), respectively. From the above dis-
cussion it is clear that the structure of the compound has a
marked effect on their biological activities.
Synthesis of 2,5-dimethyl pyrrole and 1,3-benzoxazin-4-one derivatives S3993. Experimental
3.1. Physical apparatus
Undec-10-enoic acid (purity 98%) and octadec-9Z-enoic acid
(purity 97%) were purchased commercially from the Fluka
Chemicals (Switzerland). (9Z, 12R)-12-Hydroxyoctadec-9-
enoic (Ricinolic) and (9R, 12Z)-9-hydroxyoctadec-12-enoic
acid (Isoricinolic) were extracted from the naturally occur-
ring seeds; Ricinus communis and Wrightia tinctoria, through
Gunstone’s partitioning method [41,42]. The fatty acids
obtained by this method were further puriﬁed by the column
chromatography. Laboratory grade chemicals were used for
the puriﬁcation. Acetonyl acetone (2,5-hexadione), anthra-
nilic acid (amino benzoic acid), phosphorus oxychloride
(POCl3) and pyridine were purchased commercially from
the Sd-ﬁne Chemicals, Mumbai, India. Melting points were
taken in glass capillaries and are uncorrected. Formation
of the product was determined by TLC (thin layer chroma-
tography) plates, coated with silica gel-G and spots were
visualized in the iodine chamber. All the synthesized com-
pounds were characterized by IR, 1H NMR, 13C NMR
and mass spectra.
IR spectra were taken on the Shimadzu 8201 FT-IR instru-
ment and wave lengths were recorded in cm1. 1H NMR
spectra were obtained from Brucker Avance II instrument,
spectra were recorded at 400 MHz in CDCl3.
13C NMR spec-
tra were recorded at 100 MHz. Chemical shifts for both 1H
NMR and 13C NMR, were quoted in ppm and were measured
relative to the standard TMS (tetra methyl silane). Coupling
constant (J) are expressed in Hertz. Mass spectra of the test
compounds were obtained on a Jeol SX-102 spectrometer.
The puriﬁcation of the synthesized compounds was carried
out by column chromatography.
3.2. Synthesis
3.2.1. General procedure of the synthesis of fatty acid hydrazides
1(a–e)
The hydrazides of fatty acid were synthesized according to the
previously synthesized reported method [43].
3.2.2. General procedure for the synthesis of compounds 2(a–e)
Take 0.01 mol of fatty acid hydrazide and 0.02 mol acetonyl
acetone (2,5-hexadione) in a round bottom ﬂask. Dissolve
the reaction mixture in about 30 ml of ethanol (EtOH). Reﬂux
this mixture on water bath at temperature of 80 C. Progress of
the reaction was monitored by the TLC, after completion con-
centrate the reaction mixture, up to half of its original volume
by opening the corks of a round bottom ﬂask. Now pour the
reaction mixture into crushed ice, solid was obtained. Precipi-
tate was ﬁltered and further puriﬁcation was done through
crystallization from ethanol solvent. Spectra of the synthesized
compounds are given below.
3.2.2.1. N-(20,50-dimethyl pyrrol-10-yl)-hexadecamide 2(a). IR
(KBr, cm1): 3273 (NH stretch), 2919 (CH asymmetric),
2848 (CH symmetric), 1672 (amide C‚O), 1096 (C–N stretch);
1H NMR (400 MHz, d, ppm, CDCl3): 8.15 (s, 1H, CONH),
5.79 (d, 2H, ring protons), 2.34 (t, 2H, J= 7.52 Hz, CH2CO),2.08 (s, 6H, methyl substituents), 1.74 (m, 2H, CH2CH2CO),
1.25 (broad singlet, 24H, (CH2)12), 0.88 (distorted triplet,
3H, CH3CH2);
13C NMR (100 MHz, d, ppm, CDCl3): 168.1,
127.2, 126.8, 104.5, 103.2, 33.9, 33.7, 32.5, 31.8, 31.1, 30.9,
30.4, 29.9, 29.7, 28.7, 28.4, 27.6, 26.1, 25.2, 14.8, 12.0, 11.7;
MS (m/z): 371.3 [M+Na]+, Calculated for
C22H40N2O = 371.4.
3.2.2.2. N-(20,50-dimethyl pyrrol-10-yl)-10-enyl-undecamide
2(b). IR (KBr, cm1): 3259, 3228 (NH stretch), 2923 (CH
asymmetric), 2856 (CH symmetric), 1673 (amide C‚O),
1082 (C–N stretch); 1H NMR (400 MHz, d, ppm, CDCl3):
7.98 (s, 1H, CONH), 5.76 (tdd, 1H, JH9CH2 = 5.9 Hz, J H-
Hz = 10.2 Hz, JHHE = 16.4 Hz, CH2‚CH), 5.72 (d, 2H,
J= 10.3 Hz, ring protons), 4.91 (dd, 1H, JHz-H = 10.2 Hz,
JHEHZ = 1.8 Hz, zHC‚CH), 4.85 (dd, 1H,
JHEH = 16.4 Hz, JHEHZ = 1.8 Hz, EHC‚CH), 2.72 (t, 2H,
J= 7.6 Hz, CH2CO), 2.00 (s, 6H, methyl substituents), 1.66
(m, 2H,‚CHACH2), 1.54 (m, 2H, CH2CH2CO), 1.26 (broad
singlet, 10H, (CH2)5);
13C NMR (100 MHz, d, ppm, CDCl3):
165.2, 134.5, 133.6, 126.7, 125.3, 104.2, 103.1, 29.8, 29.5,
28.7, 26.5, 26.1, 25.2, 24.3, 22.8, 11.9, 11.6; MS (m/z): 299.2
[M+Na]+, Calculated for C17H28N2O = 299.3.
3.2.2.3. N-(20,50-dimethyl pyrrol-10-yl)-9-enyl-octadecamide
2(c). IR (KBr, cm1): 3233, 3224 (NH stretch), 2923 (CH
asymmetric), 2855 (CH symmetric), 1676 (amide C‚O),
1080 (C–N stretch); 1H NMR (400 MHz, d, ppm, CDCl3):
8.02 (s, 1H, CONH), 5.82 (d, 2H, J= 11.5 Hz, ring protons),
5.36 (m, 2H, CH‚CH), 2.26 (t, 2H, J= 7.5 Hz, CH2CO),
2.09 (s, 6H, methyl substituents), 1.75 (m, 2H, CH2CH2CO),
1.73 (m, 4H, CH2–CH‚CHACH2), 1.27 (broad singlet,
18H, (CH2)9), 1.05 (m, 2H, CH2CH3), 0.89 (distorted triplet,
3H, CH3CH2);
13C NMR (100 MHz, d, ppm, CDCl3): 167.8,
135.5, 134.6, 128.7, 126.9, 105.1, 104.7, 40.8, 39.7, 38.7, 37.6,
34.2, 33.1, 31.5, 28.9, 27.0, 25.1, 24.4, 23.7, 22.8, 22.0, 14.2,
11.9, 11.0; MS (m/z): 397.5 [M+Na]+, Calculated for
C24H42N2O = 397.5.
3.2.2.4. N-(20,50-dimethyl pyrrol-10-yl)-(9Z, 12R)-9-enyl-12-
hydroxyoctadecamide 2(d). IR (KBr, cm1): 3407 (OH
stretch), 3249, 3237 (NH stretch), 2925 (CH asymmetric),
2851 (CH symmetric), 1675 (amide C‚O), 1076 (C–N stretch);
1H NMR (400 MHz, d, ppm, CDCl3): 8.07 (s, 1H, CONH),
5.72 (d, 2H, J= 11.1 Hz, ring protons), 5.40 (m, 2H,
CH‚CH), 3.54 (m, 1H, CH2CH(OH)), 2.27 (t, 2H,
J= 7.6 Hz, CH2CO), 2.13 (m, 4H, CH2-CH‚CHACH2),
2.05 (s, 6H, methyl substituents), 1.90 (m, 2H, CH2CH2CO),
1.79 (m, 2H, CH2CH(OH)–), 1.67 (m, 1H, CH2CH(OH)–),
1.38 (m, 2H, CH2CH3), 1.21 (broad singlet, 16H, (CH2)8),
0.81 (distorted triplet, 3H, CH3CH2);
13C NMR (100 MHz,
d, ppm, CDCl3): 168.2, 138.7, 137.6, 127.7, 126.9, 104.2,
103.2, 68.6, 39.8, 38.7, 37.5, 36.6, 35.3, 35.0, 34.8, 31.8, 29.3,
26.5, 23.1, 14.5, 10.9, 10.7; MS (m/z): 413.4 [M+Na]+, Calcu-
lated for C24H42N2O2 = 413.5.
3.2.2.5. N-(20,50-dimethyl pyrrol-10-yl)-(9Z, 12R)-9-enyl-12-
hydroxyoctadecamide 2(e). IR (KBr, cm1): 3410 (OH
stretch), 3240, 3234 (NH stretch), 2928 (CH asymmetric),
2854 (CH symmetric), 1671 (amide C‚O), 1081 (C–N stretch);
1H NMR (400 MHz, d, ppm, CDCl3): 8.10 (s, 1H, CONH),
5.73 (d, 2H, J= 10.9 Hz, ring protons), 5.46 (m, 2H,
S400 H. Varshney et al.CH‚CH), 3.52 (m, 1H, CH2CH(OH)–), 2.26 (t, 2H,
J= 7.4 Hz, CH2CO), 2.14 (m, 4H, CH2–CH‚CH‚CH2),
2.05 (s, 6H, methyl substituents), 1.88 (m, 2H, CH2CH2CO),
1.81 (m, 2H, CH2CH(OH)-), 1.69 (m, 1H, CH2CH(OH)–),
1.37 (m, 2H, CH2 CH3), 1.19 (broad singlet, 16H, (CH2)8),
0.79 (distorted triplet, 3H, CH3CH2);
13C NMR (100 MHz,
d, ppm, CDCl3): 169.0, 139.8, 138.8, 129.3, 127.4, 106.0,
105.1, 68.4, 38.9, 38.6, 37.1, 36.0, 34.9, 34.7, 33.9, 32.7, 30.1,
28.7, 26.5, 14.9, 11.9, 10.9; MS (m/z): 413.3 [M+Na]+, Calcu-
lated for C24H42N2O2 = 413.5.
3.2.3. General procedure for the synthesis of fatty acid esters
3(b–e)
Methyl esters of fatty acids were synthesized by reﬂuxing the
fatty acids in methanol in the presence of catalytic amount
of concentrated H2SO4 [44].
3.2.4. General procedure for the synthesis of compounds 4(b–e)
A mixture of 0.01 mol of fatty acid methyl ester and 0.01 mol
of anthranilic acid were dissolved in 35 ml dry benzene. In the
presence of catalytic amount of pyridine, reﬂux the reaction
mixture on water bath for 6–8 h or till complete conversion
of ester into the product. After cooling, the reaction mixture
was gradually poured into the diluted HCl, then worked up
with dichloromethane–water. An oily liquid was obtained;
purify this liquid by column chromatography. Spectra of the
synthesized compounds are given below.
3.2.4.1. 2-(Dec-90-enyl)-1,3-benzoxazin-4-one 4(b). IR (KBr,
cm1): 3075 (CH aromatic), 2924 (CH asymmetric), 2852
(CH symmetric), 1659 (amide C‚O), 1523 (C‚N), 1090 (C–
N stretch), 1158–786 (C–C); 1H NMR (400 MHz, d, ppm,
CDCl3): 8.35–7.33 (m, 4H, aromatic protons), 5.80 (tdd, 1H,
JH9CH2 = 5.8 Hz, JH-Hz = 10.1 Hz, JHHE = 16.2 Hz, CH2-
‚CH), 4.99 (dd, 1H, JHz-H = 10.1 Hz, JHEHZ = 3.0 Hz, z-
HC‚CH), 4.92 (dd, 1H, JHEH = 16.2 Hz, JHEHZ = 3.0 Hz,
EHC‚CH), 2.30 (t, 2H, J= 7.4 Hz, CH2C–O), 1.60 (m, 2H,
‚CHACH2), 1.36 (m, 2H, CH2CH2CAO), 1.25 (broad sin-
glet, 10H, (CH2)5);
13C NMR (100 MHz, d, ppm, CDCl3):
174.4, 171.2, 142.2, 134.3, 131.6, 130.8, 129.9, 128.2, 124.5,
122.6, 37.9, 35.1, 29.6, 27.1, 25.5, 22.5, 22.3; MS (m/z): 308.4
[M+Na]+, Calculated for C18H23O2N= 308.3.
3.2.4.2. 2-(Octadec-80-enyl)-1,3-benzoxazin-4-one 4(c). IR
(KBr, cm1): 3064 (CH aromatic), 2925 (CH asymmetric),
2858 (CH symmetric), 1631 (amide C‚O), 1539 (C‚N),
1002 (C–N stretch), 1167–750 (C–C); 1H NMR (400 MHz, d,
ppm, CDCl3): 8.68–6.99 (m, 4H, aromatic protons), 5.28 (m,
2H, CH‚CH), 2.36 (t, 2H, J= 7.6 Hz, CH2C–O), 1.95 (m,
4H, CH2CH‚CHCH2), 1.67 (m, 2H, CH2CH2CAO), 1.53
(m, 2H, CH2 CH3), 1.26 (broad singlet, 18H, (CH2)9), 0.80
(distorted triplet, 3H, CH3CH2);
13C NMR (100 MHz, d,
ppm, CDCl3): 174.5, 172.7, 142.0, 135.1, 130.1, 130.0, 128.0,
127.9, 123.8, 122.4, 38.6, 34.1, 31.9, 31.5, 30.2, 29.7, 29.5,
28.1, 27.2, 26.4, 25.6, 24.9, 22.6, 14.1; MS (m/z): 406.3
[M+Na]+, Calculated for C25H37O2N= 406.4.
3.2.4.3. 2-[(80R,110Z)-80-Hydroxyoctadec-110-enyl]-1,3-benz-
oxazin-4-one 4(d). IR (KBr, cm1): 3394 (OH stretch), 3014
(CH aromatic), 2927 (CH asymmetric), 2856 (CH symmetric),
1637 (amide C‚O), 1534 (C‚N), 1004 (C–N stretch), 1173–751 (C–C); 1H NMR (400 MHz, d, ppm, CDCl3): 8.74–7.08
(m, 4H, aromatic protons), 5.45 (m, 2H, CH‚CH), 3.50 (m,
1H, CH2CH(OH)–), 2.44 (t, 2H, J= 7.1 Hz, CH2CAO),
2.27 (m, 4H, CH2CH‚CHCH2), 1.75 (m, 1H, CH-OH), 1.63
(m, 2H, CH2CH2CAO), 1.50 (m, 2H, CH2CHOH), 1.24
(broad singlet, 16H, (CH2)8), 0.89 (distorted triplet, 3H, CH3-
CH2);
13C NMR (100 MHz, d, ppm, CDCl3): 179.3, 172.3,
141.8, 135.0, 132.5, 131.6, 125.1, 124.8, 122.4, 120.3, 65.9,
38.5, 36.4, 35.2, 34.0, 31.8, 29.3, 28.8, 27.3, 25.6, 25.3, 24.6,
22.5, 15.2, 14.3; MS (m/z): 422.2 [M+Na]+, Calculated for
C25H37O3N = 422.4.
3.2.4.4. 2-[(80Z,110R)-110-Hydroxyoctadec-80-enyl]-1,3-benz-
oxazin-4-one 4(e). IR (KBr, cm1): 3401 (OH stretch), 3034
(CH aromatic), 2928 (CH asymmetric), 2857 (CH symmetric),
1648 (amide C‚O), 1537 (C‚N), 1028 (C–N stretch), 1159–
772 (C–C); 1H NMR (400 MHz, d, ppm, CDCl3): 8.72–7.10
(m, 4H, aromatic protons), 5.44 (m, 2H, CH‚CH), 3.53 (m,
1H, CH2CHOH), 2.45 (t, 2H, J= 7.2 Hz, CH2C–O), 2.27
(m, 4H, CH2CH‚CHCH2), 1.73 (m, 1H, CH–OH), 1.62 (m,
2H, CH2CH2CAO), 1.51 (m, 2H, CH2CHOH), 1.29 (broad
singlet, 16H, (CH2)8), 0.87 (distorted triplet, 3H, CH3CH2);
13C NMR (100 MHz, d, ppm, CDCl3): 178.7, 171.5, 140.7,
133.3, 132.7, 131.8, 125.6, 124.3, 121.9, 120.8, 66.1, 37.6,
36.5, 35.8, 34.6, 31.9, 29.7, 29.1, 27.4, 25.8, 25.4, 24.9, 23.0,
22.1, 20.7, 14.6; MS (m/z): 422.5 [M+Na]+, Calculated for
C25H37O3N = 422.4.
3.3. Biological activity
3.3.1. In vitro antibacterial studies
All the newly synthesized novel compounds were dissolved in
DMSO to prepare a stock solution of 1 mg/ml. The antibacte-
rial activity of test compounds and standard ciproﬂoxacin was
carried out by the ﬁlter paper disc method [45]. Media with
DMSO were set up as control. All cultures were consistently
maintained on NA (nutrient agar) and incubated overnight
at 37 C. The culture was centrifuged at 1000 rpm and pellets
were resuspended then diluted in sterile NSS (normal saline
solution) to obtain viable count 105 cfu/ml. About, 0.1 ml of
diluted bacterial culture suspension was spread accordingly
with the help of spreader on NA plates. Sterile discs of thick-
ness 8 mm (Hi-Media Pvt. Ltd.) were impregnated with the test
compounds. Antibiotic disc, ciproﬂoxacin (30 lg/disc Hi-
Media) was used as control. The disc was placed on the nutri-
ent agar plate. Each plate had one control disc impregnated
with the solvent. The plates were then incubated for 24 h at
37 C, and the resulting zones of inhibition were measured in
mm.
3.3.2. In vitro antifungal studies
The synthesized compounds were dissolved in DMSO and
media with DMSO were set up as control. All cultures were
consistently maintained on SDA (sabouraud’s dextrose agar)
and incubated at 28 C. Spore formation of ﬁlamentous fungi
was prepared from 7 day old culture in sterile normal solution
(8% NaCl) and approximately diluted to obtain 105 cfu/ml.
The inoculums of non-sporing fungi, C. albicans were per-
formed by growing the culture in SD (sabouraud’s) broth at
37 C for overnight. The culture was centrifuged at 1000 rpm
and pellets were resuspended and diluted in sterile NSS (nor-
Synthesis of 2,5-dimethyl pyrrole and 1,3-benzoxazin-4-one derivatives S401mal saline solution) to obtain viable count 105 cfu/ml. About,
0.1 ml of diluted fungal culture suspension was spread
uniformly with the help of spreader on SDA plates. Sterile
discs (Hi-Media Pvt. Ltd.) were impregnated with the test com-
pounds. Antibiotic disc, nystatin (30 lg/disc Hi-Media) was
used as control. The disc was placed on the SDA plate. Each
plate had one control disc impregnated with the solvent. The
plates were incubated at 28 C for ﬁlamentous fungi for 72 h
or more, while for C. albicans plates were incubated at 37 C
for 18–48 h. Antifungal activity was determined by measuring
the diameters of the inhibition zone (in mm).4. Conclusions
Here we report the synthesis of two different types of series of
heterocyclic derivatives of fatty acids synthesized from the two
different substrates. The method reported here for the synthe-
sis of substituted-2,5-dimethyl pyrrole and 1,3-benoxazin-4-
one derivatives, was easy and convenient one, which includes
the use of safe and cheaper chemicals. The compounds
obtained from the synthesis were in appreciable yield. All these
compounds were found to be good antimicrobial agents. Com-
pounds 2d, 2e, 4d and 4e showed excellent antibacterial activity
against gram-negative bacteria and good activity against gram-
positive bacteria. These compounds were also found to be
good antifungal agent against C. albicans species. On the basis
of the above mentioned antimicrobial results, these com-
pounds showed promising results in the ﬁeld of pharmaceutical
chemistry for future development.Acknowledgments
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